Liver fluke (fascioliasis)
Hardi Marif, Zana Mustafa Rashid, Hawsar Othman Muhamad
Abstract
Hardi Marif, Zana Mustafa Rashid, Hawsar Othman Muhamad
Abstract
Liver fluke (fascioliasis) is a parasitic disease caused by a trematode parasite of the genus Fasciola. The fluke occur mainly in animals (cattle, sheep, goats and occasionally equine) but human can be infected. Human fascioliasis has recently been recognised as an emerging and re-emerging zoonotic disease in several countries. Approximately 17 million people have been infected and 180 million people at risk all over the world. Fascioliasis is a major problem in the field of veterinary public health as well as a great impact on economic losses. The disease can be diagnosed by faecal examination of excreted eggs however; it is not reliable in horses. In addition, molecular techniques, ELISA and Western Blot tests can be applied to confirm the diagnosis. Triclabendazole, Rafoxanide and Closantel are used for the treatment of fascioliasis but resistance has been recorded in some countries. No commercial vaccine is yet available in spite of many trials. In this review, we aim to shed light on the life cycle, diagnosis, treatment, resistance and control of Fasciola in details.
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Liver fluke (fascioliasis) is a parasitic disease caused by a trematode parasite of the genus Fasciola. The fluke occur mainly in animals (cattle, sheep, goats and occasionally equine) but human can be infected. Human fascioliasis has recently been recognised as an emerging and re-emerging zoonotic disease in several countries. Approximately 17 million people have been infected and 180 million people at risk all over the world. Fascioliasis is a major problem in the field of veterinary public health as well as a great impact on economic losses. The disease can be diagnosed by faecal examination of excreted eggs however; it is not reliable in horses. In addition, molecular techniques, ELISA and Western Blot tests can be applied to confirm the diagnosis. Triclabendazole, Rafoxanide and Closantel are used for the treatment of fascioliasis but resistance has been recorded in some countries. No commercial vaccine is yet available in spite of many trials. In this review, we aim to shed light on the life cycle, diagnosis, treatment, resistance and control of Fasciola in details.
Key concepts: Triclabendazole, Fasciola, Liver fluke, Parasitic disease, Fasciola hepatica, Veterinary medicine, Veterinary public health, Fasciolosis